1,3-Bis(2,6-diisopropylphenyl)imidazolium-2-carboxylate

Catalog No. :
ACPNZR190
CAS No. :
917604-39-8
Molecular Formula :
C28H36N2O2
Molecular Weight :
432.61

IUPAC Name:1,3-bis(2,6-diisopropylphenyl)-1H-imidazol-3-ium-2-carboxylate

1,3-Bis(2,6-diisopropylphenyl)imidazolium-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$115.00Login to see priceInquiryInquiry
1g98%$283.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Bis(2,6-diisopropylphenyl)imidazolium-2-carboxylate
IUPAC Name1,3-bis(2,6-diisopropylphenyl)-1H-imidazol-3-ium-2-carboxylate
MDL No.MFCD31618109
Molecular FormulaC28H36N2O2
Molecular Weight432.61
SMILESO=C(C1=[N+](C2=C(C(C)C)C=CC=C2C(C)C)C=CN1C3=C(C(C)C)C=CC=C3C(C)C)[O-]
InChI KeyYJFHWSQOLOIECF-UHFFFAOYSA-N
SynonymT71456 | DTXSID00580837 | 1,3-bis[2,6-di(propan-2-yl)phenyl]imidazol-1-ium-2-carboxylate | CS-0095856 | SCHEMBL16909944 | B5603 | 1,3-Bis[2,6-di(propan-2-yl)phenyl]-1H-imidazol-3-ium-2-carboxylate | IPr.CO2 | MFCD31618109 | 1,3-bis(2,6-diisopropylphenyl)i
CAS No.917604-39-8
PubChem CID15984494

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACPNZR190 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPNZR190 route product structure diagram
    ACPNZR190917604-39-8
Inquiry

2. ACPNZR190 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTXUV501 route compound structure diagram
    ACTXUV501363166-79-4 In Stock
  4. Then
  5. ACPNZR190 route product structure diagram
    ACPNZR190917604-39-8
Inquiry

Comments (0)